Sign In
Buy GNPX
$0.720
-0.0153 (-2.08%)
At Close: Jun 03, 2026
Genprex to Present at the MoneyShow June Virtual Event
12:00am, Monday, 08'th Jun 2020
Genprex's CEO will Present at the MoneyShow Virtual Event on June 10
ASCO 2020 round-up: Virtual conference still delivers the drama -
11:00am, Friday, 05'th Jun 2020
ASCO may have been virtual this year because of the COVID-19 pandemic, but there were still some show-stopping moments, reports Richard Staines
Stock Charts To Watch: Airlines, Medical And A Little Coffee
12:00am, Friday, 05'th Jun 2020
Stocks Analysis by Harry Boxer covering: Alcoa Corp, Bed Bath & Beyond Inc, Allegheny Technologies Incorporated, Target Corporation. Read Harry Boxer's latest article on Investing.com
Regulatory News: NANOBIOTIX (Paris:NANO)(Euronext: NANO - ISIN: FR0011341205 – la « Société »), société française pionnière en nanomédecine développan
Genprex Announces Receipt of $2.5 Million in Cash from Recent Warrant Exercises
12:17pm, Thursday, 28'th May 2020
Genprex Announces Receipt of $2.5 Million in Cash from Recent Warrant Exercises
Yearly Gainers: $CODX $NVAX $GNPX
02:38pm, Tuesday, 26'th May 2020
May 26, 2020 (The Market Signal via Comtex) --
Sector Reports was created as a platform to help investors find the best free Stock Reports on stocks they...
Week In Review: CanSino Publishes Positive Data From Trial Of COVID-19 Vaccine
02:47pm, Sunday, 24'th May 2020
Moderna, a Boston-area mRNA company, reported positive early data from a Phase I trial of its coronavirus vaccine. Sinovac Biotech of Beijing raised $15 million
Hospital revenues fall as coronavirus epidemic keeps people home
02:43am, Friday, 15'th May 2020
Halted surgical procedures and increasing personal protective equipment expenses drove hospital revenues and patient volumes down in the past two months, according to a Crowe LLP report.
Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q1 2020 Results - Earnings Call Transcript
12:33am, Friday, 15'th May 2020
Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Company Participants Avi Oler - Vice President, Corporate Dev
Kiromic BioPharma Files For IPO
01:24am, Thursday, 14'th May 2020
Kiromic BioPharma has filed to raise $20 million in a U.S. IPO, although the final figure may differ. The firm is advancing programs for the treatment of lympho
Communist China Continues to Target American Creativity
05:45pm, Wednesday, 13'th May 2020
Commentary In mid-April, a senior FBI official warned that cyber spies were attacking U.S. and allied medical research ...
8-K: BioXcel Therapeutics, Inc.
03:39am, Wednesday, 13'th May 2020
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange...
Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q1 2020 Results - Earnings Call Transcript
03:05am, Wednesday, 13'th May 2020
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q1 2020 Results Earnings Conference Call May 12, 2020, 04:30 PM ET Company Participants Jan Medina - Investor Relat
Merck’s Novel HIF-2α Inhibitor Showed an Objective Response Rate of Nearly 30% in Patients with VHL Disease-Associated Clear Cell Renal Cell Carcinoma
